Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), et al., “Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension,” European Respiratory Journal, Vol. 34, No. 6, 2009, pp. 1219-1263. http://dx.doi.org/10.1183/09031936.00139009
 P. Dartevelle, E. Fadel, S. Mussot, et al., “Chronic Thromboembolic Pulmonary Hypertension,” European Respiratory Journal, Vol. 23, No. 4, 2004, pp. 637-648. http://dx.doi.org/10.1183/09031936.04.00079704
 A. Chapelier, P. Vouhé, P. Macchiarini, et al., “Comparative Outcome of Heart-Lung and Lung Transplantation for Pulmonary Hypertension,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 106, No. 2, 1993, pp. 299-307.
 E. Fadel, G. M. Mazmanian, B. Baudet, et al., “Endothelial Nitric Oxide Synthase Function in Pig Lung after Chronic Pulmonary Artery Obstruction,” American Journal of Respiratory and Critical Care Medicine, Vol. 162, No. 4, 2000, pp. 1429-1434. http://dx.doi.org/10.1164/ajrccm.162.4.2001010
 D. M. Smadja, L. Mauge, O. Sanchez, et al., “Distinct patterns of Circulating Endothelial Cells in Pulmonary Hypertension,” European Respiratory Journal, Vol. 36, No. 6, 2010, pp. 1284-1293. http://dx.doi.org/10.1183/09031936.00130809
 F. Ius, C. Kuehn, I. Tudorache, et al., “Lung Transplantation on Cardiopulmonary Support: Venoarterial Extracorporeal Membrane Oxygenation Outperformed Cardiopulmonary Bypass,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 144, No. 6, 2012, pp. 1510-1516. http://dx.doi.org/10.1016/j.jtcvs.2012.07.095
 K. Kotani, S. Ichiba, M. Andou, et al., “Extracorporeal Membrane Oxygenation with Nafamostat Mesilate as an Anticoagulant for Massive Pulmonary Hemorrhage after Living-Donor Lobar Lung Transplantation,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 124, No. 3, 2002, pp. 626-627. http://dx.doi.org/10.1067/mtc.2002.125638